• LAST PRICE
    1.6600
  • TODAY'S CHANGE (%)
    Trending Down-0.0400 (-2.3529%)
  • Bid / Lots
    1.6600/ 235
  • Ask / Lots
    1.7600/ 250
  • Open / Previous Close
    1.7000 / 1.7000
  • Day Range
    Low 1.6100
    High 1.7900
  • 52 Week Range
    Low 0.8906
    High 2.4300
  • Volume
    427,984
    below average

Search Criteria

Filter search criteria using below inputs

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
CompanyCountrySymbol
Select an index
Price Comparison Graph. See accessible table below
1 Day Comparison Chart Accessibility Table. Thursday's close: 1.7
TimeVolumePSNL
09:32 ET152871.7449
09:34 ET98391.77
09:38 ET78001.759
09:39 ET44001.75
09:41 ET133971.7703
09:43 ET1501.775
09:45 ET12491.78
09:48 ET44371.7881
09:52 ET40001.78
09:56 ET32001.77
09:57 ET1001.76
10:03 ET21001.74
10:06 ET13001.73
10:12 ET12001.76
10:14 ET36951.75
10:15 ET11001.765
10:17 ET21001.76
10:21 ET32001.76
10:24 ET9001.76
10:26 ET8001.76
10:30 ET32601.7601
10:32 ET2001.765
10:33 ET10001.768
10:35 ET52441.765
10:39 ET5171.7607
10:42 ET13981.775
10:44 ET12001.775
10:46 ET1001.775
10:48 ET26091.74
10:55 ET3001.7201
10:57 ET2001.72
11:00 ET67331.701
11:02 ET5801.701
11:04 ET29191.71
11:06 ET8001.7
11:09 ET66071.7
11:11 ET126051.68
11:13 ET20151.68
11:15 ET23131.69
11:18 ET19001.709
11:20 ET11001.73
11:22 ET25001.72
11:24 ET279391.69
11:26 ET20451.72
11:27 ET4001.714
11:29 ET109001.725
11:31 ET84021.7299
11:33 ET1001.73
11:36 ET2001.72
11:38 ET8501.73
11:40 ET1001.73
11:42 ET138921.7299
11:44 ET1001.725
11:45 ET4001.7216
11:47 ET18001.725
11:49 ET11601.7296
11:51 ET5001.725
11:54 ET3001.72
11:56 ET2001.73
11:58 ET12001.725
12:00 ET2001.7272
12:02 ET2001.725
12:03 ET15951.7299
12:05 ET3001.73
12:07 ET30001.7
12:09 ET12401.69
12:12 ET9991.6901
12:14 ET1001.69
12:23 ET2031.691
12:25 ET8271.681
12:32 ET1001.68
12:34 ET18471.6706
12:36 ET11001.665
12:39 ET1001.66
12:41 ET56501.64
12:43 ET13001.65
12:45 ET10001.6403
12:50 ET3001.66
12:52 ET28001.66
12:54 ET34291.66
12:56 ET9001.66
12:57 ET17501.6639
01:01 ET13001.665
01:03 ET2001.664
01:06 ET4001.65
01:15 ET2001.654
01:19 ET1851.655
01:21 ET12451.66
01:30 ET10831.66
01:33 ET67161.665
01:35 ET8001.66
01:37 ET13001.665
01:39 ET10591.665
01:44 ET34001.65
01:48 ET4501.6401
01:51 ET21001.642
01:55 ET10001.6475
01:57 ET24001.63
02:00 ET9991.63
02:02 ET1001.625
02:04 ET1001.62
02:08 ET1001.625
02:09 ET9001.624
02:11 ET1151.6215
02:13 ET3081.624
02:15 ET11001.615
02:18 ET4221.615
02:22 ET4001.62
02:24 ET3001.61
02:26 ET1001.62
02:29 ET13001.62
02:33 ET1001.628
02:36 ET1391.62
02:40 ET16001.6285
02:44 ET18221.63
02:45 ET7891.64
02:47 ET225511.635
02:49 ET1001.635
02:51 ET4601.63
02:54 ET2001.635
02:56 ET4001.635
02:58 ET3001.635
03:02 ET11001.635
03:03 ET5001.63
03:05 ET1001.635
03:07 ET3001.63
03:09 ET1001.635
03:12 ET4001.63
03:14 ET3001.63
03:16 ET15001.635
03:18 ET13001.635
03:20 ET11391.62
03:21 ET2001.625
03:23 ET13001.62
03:25 ET10961.62
03:27 ET2001.625
03:30 ET4001.625
03:32 ET87671.62
03:34 ET142111.625
03:36 ET75581.63
03:38 ET18451.635
03:39 ET1801.635
03:41 ET16341.645
03:43 ET43471.66
03:45 ET31901.65
03:48 ET41001.66
03:50 ET6001.66
03:52 ET10001.67
03:54 ET5451.67
03:56 ET24251.66
03:57 ET41681.67
03:59 ET303081.66
Data delayed at least 15 minutes.
Industry Peers Overview Table
Company sortableMarket Cap sortableP/E Ratio (TTM) sortableEPS Growth (5yr) sortable
United StatesPSNL
Personalis Inc
86.2M
-0.9x
---
United StatesMDXH
MDxHealth SA
76.1M
-2.0x
---
United StatesPLX
Protalix Biotherapeutics Inc
83.6M
18.8x
---
United StatesBIOQ
Bioqual Inc
64.8M
67.8x
-25.28%
United StatesCDTX
Cidara Therapeutics Inc
52.4M
-1.4x
---
United StatesFBIO
Fortress Biotech Inc
43.3M
-0.3x
---
As of 2024-07-13

Company Information

Personalis, Inc. is engaged in developing and marketing advanced cancer genomic tests and analytics. The Company’s advanced genomic sequencing and analytics support the development of personalized cancer vaccines and other next generation cancer immunotherapies. Its products include NeXT Personal, ImmunoI DNeXT, NeXT Personal Dx, NeXT Dx, whole exome sequencing (WES), and whole genome sequencing (WGS). NeXT Personal is a tumor-informed liquid biopsy test for detection of minimal residual disease (MRD) and recurrence in cancer. NeXT Dx is a comprehensive tumor profiling test that unlocks the entire exome (DNA) and transcriptome (RNA) with matched tumor-normal analysis. The Company performed WGS on human samples for research projects, such as population sequencing initiatives. The Company’s tests and analytics are used by pharmaceutical companies for translational research, biomarker discovery, the development of personalized cancer therapies.

Contact Information

Headquarters
6600 Dumbarton CircleFREMONT, CA, United States 94555
Phone
650-752-1300
Fax
302-531-3150

Executives

Independent Chairman of the Board
Karin Eastham
President, Chief Executive Officer, Director
Christopher Hall
Chief Financial Officer, Chief Operating Officer, Senior Vice President
Aaron Tachibana
Executive Vice President - Research and Development, Chief Medical Officer
Richard Chen
Senior Vice President, Chief Legal Officer, and Corporate Secretary
Stephen Moore

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals Table
Market Cap
$86.2M
Revenue (TTM)
$74.1M
Shares Outstanding
51.9M
Dividend Yield
0.00%
Annual Dividend Rate
---
Ex-Dividend Date
01-01-01
Pay Date
01-01-01
Beta
1.90
EPS
$-1.89
Book Value
$2.56
P/E Ratio
-0.9x
Price/Sales (TTM)
1.2
Price/Cash Flow (TTM)
---
Operating Margin
-133.51%
*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.